Ricovir EM Tablet

Get a Price/Quote

MOQ : 215 Bottles

Ricovir EM Tablet Specification

Dosage Form
Tablet

Life Span
24 months from date of manufacture

Pacakaging (Quantity Per Box)
30 tablets per box

Packaging Type
Blister pack/Box

Origin of Medicine
INDIA

Indication
HIV-1 infection and HIV pre-exposure prophylaxis (PrEP)

Salt Composition
Emtricitabine 200mg + Tenofovir Disoproxil Fumarate 300mg

Brand Name
Ricovir-EM

Drug Type
Allopathic

Ingredients
Emtricitabine & Tenofovir Disoproxil Fumarate

Physical Form
Tablets

Function
Antiretroviral medication

Recommended For
DOCTOR

Dosage
As directed by physician

Dosage Guidelines
Take orally, once daily, with or without food

Suitable For
Adults

Quantity
215 Boxes

Storage Instructions
Store below 30C in a dry place, protect from light

MRP (Maximum Retail Price)
As per current market, subject to change

Color
Blue

Therapeutic Class
Antiviral Agents / Nucleoside Reverse Transcriptase Inhibitors (NRTIs)

Side Effects
Nausea, headache, fatigue, dizziness, gastrointestinal disturbances

Warning
Not recommended for patients with severe renal impairment without dose adjustment

Approval
WHO Prequalification, USFDA and other regulatory approvals (for APIs)

Administration Route
Oral

Prescription/Non prescription
Prescription

Shape
Oval

Ricovir EM Tablet Trade Information

Minimum Order Quantity
215 Bottles

Delivery Time
1 Week

About Ricovir EM Tablet

Ricovir EM Tablet is an effective antiretroviral treatment that combines emtricitabine and tenofovir disoproxil fumarate, specifically designed for adults and adolescents aged 12 years and above who weigh at least 35 kg and are living with Human Immunodeficiency Virus type 1 (HIV-1). This powerful medication works by inhibiting the replication of the virus, thereby helping to manage HIV infection and significantly reducing the risk of progression to acquired immunodeficiency syndrome (AIDS). When taken as prescribed, Ricovir EM can enhance the quality of life for those affected by HIV, but it's crucial to adhere to the treatment plan to achieve optimal results. Patients should be aware of potential side effects and discuss any pre-existing health conditions with their healthcare provider to ensure safe usage. Regular monitoring and follow-up appointments are essential to assess the effectiveness of the treatment and make any necessary adjustments. For those seeking a reliable solution in their fight against HIV, Ricovir EM Tablet offers a promising option. Always consult your healthcare professional before starting any new medication to ensure it's right for you.

Reliable Antiretroviral Therapy

Ricovir EM provides a trusted and effective option for managing HIV-1 infection and for pre-exposure prophylaxis (PrEP). It contains a combination of Emtricitabine and Tenofovir Disoproxil Fumarate, working together to inhibit viral replication, thus reducing viral load and transmission risk. The dual action offers potent protection and forms a cornerstone in antiretroviral treatment.

Easy Oral Administration and Convenient Packaging

Ricovir EM is designed for ease of use, requiring just one tablet orally once a day, with or without food. Each blister pack contains 30 tablets, making it simple for patients to adhere to their regimen. The physical form and user-friendly packaging promote convenience and support consistent daily use.

Approved Quality and Safety Standards

Manufactured in India, Ricovir EM meets rigorous safety and quality criteria. The medicine is prequalified by the WHO and has received USFDA and other regulatory approvals for its active pharmaceutical ingredients. Regular monitoring and clear dosage guidelines ensure safe usage, especially in adults.

FAQ's of Ricovir EM Tablet:

Q: How should Ricovir EM Tablet be taken for optimal effectiveness?

A: Ricovir EM should be taken orally once daily, with or without food, exactly as directed by your physician. Adhering to the prescribed schedule without missing doses is important for the medication's effectiveness in HIV treatment or pre-exposure prophylaxis (PrEP).

Q: What are the main therapeutic benefits of Ricovir EM?

A: Ricovir EM helps inhibit the replication of the HIV-1 virus, thereby reducing the viral load in patients. It is effective both as a treatment for HIV-1 infection and as a preventive measure for uninfected individuals at risk, as part of PrEP.

Q: What side effects can be expected while taking Ricovir EM Tablets?

A: Some patients may experience nausea, headaches, fatigue, dizziness, or gastrointestinal disturbances. If these symptoms persist or worsen, consult your healthcare provider for further guidance.

Q: When is Ricovir EM not recommended or should be used with caution?

A: Ricovir EM is not recommended for patients with severe renal impairment unless dose adjustments are made by a healthcare professional. Always inform your doctor of any existing kidney conditions prior to starting therapy.

Q: Where is Ricovir EM manufactured and who approves its quality?

A: Ricovir EM is produced in India, and its active ingredients are approved by major authorities including WHO Prequalification, the USFDA, and other regulatory agencies, ensuring high safety and efficacy standards.

Q: What storage conditions are required for Ricovir EM Tablets?

A: Store Ricovir EM below 30C in a dry place, protected from light, to preserve its stability and effectiveness until its 24 months shelf life expires from the date of manufacture.

Q: What is the process for obtaining Ricovir EM Tablet?

A: Ricovir EM is a prescription medication and should be obtained through a doctor. Your physician will determine the appropriate dosage and duration based on your medical needs and condition.

Tell us about your requirement